Product Overview
[Drug Name]
Generic Name: Lumbrokinase Enteric-Coated Capsules
Trade Name: Pu'enfu Lumbrokinase Enteric-Coated Capsules 300,000 units x 12 capsules
[Main Ingredients]
The main ingredient of this product is a mixture of enzymes extracted and isolated from the cultivated earthworm Eisenia fetida.
[Properties]
This product is an enteric-coated capsule containing a light yellow powder.
[Indications/Main Functions]
This product is suitable for patients with elevated fibrinogen levels and platelet aggregation in ischemic cerebrovascular disease.
[Specifications]
300,000 units x 12 capsules (Pu'enfu)
[Dosage and Administration]
Oral administration: 2 capsules 3 times daily, or as directed by a physician. Take half an hour before meals. One course of treatment is 3-4 weeks. Two to three courses of treatment are acceptable, or continued until symptoms improve.
[Adverse Reactions]
A very small number of patients may experience mild headaches, dizziness, constipation, and nausea, which do not require special treatment.
[Contraindications]
This product is contraindicated in patients with allergies.
[Drug Interactions]
It may interact synergistically with drugs that inhibit platelet function.
[Precautions]
1. This product must be taken before meals. 2. Use with caution in patients with a tendency to bleed.
[Pediatric Use]
The safety and efficacy of this drug in pediatric patients have not been established.
[Elderly Use]
It is well tolerated; elderly patients can take the standard dose.
[Overdose]
This product has not been tested and no reliable references are available.
[Pharmacology and Toxicology]
Anti-metakinase is a proteolytic enzyme. Animal studies have shown that this product can dissolve pulmonary artery thrombi in rabbits and significantly shorten the time it takes for euglobulin to dissolve in rabbits.
